top of page
logo.webp

Barcelona

ISPOR Europe 2024

P1.jpg

Cost-Effectiveness Analysis - Lecanemab vs other Monoclonal Antibodies for Alzheimer’s Disease Patients

Authors:

reem.jpg

Reem Dhayan Almutair1

vaski.jpeg

Vassiki Sanogo1

images.png

Vakaramoko Diaby2

Gallery:

IMG_4223.jpg
9af7f2af-1a93-43c3-aae9-2e1920aa5856.JPG
IMG_4322.jpg

Research Heading

Integrity Life L.L.C, Orlando, Florida, USA

University of Florida, Gainesville, FL, USA

Budget Impact of Lecanemab for Alzheimer's Disease Patients Among Medicare Beneficiaries in the United States: A Subgroup Analysis

Authors:

vaski.jpeg

Vassiki Sanogo1

reem.jpg

Reem Dhayan Almutair1

wifor.jpg

Maike Schmitt3

wifor.jpg

Jan Ludwig fries3

images.png

Vakaramoko Diaby2

Gallery:

IMG_4226.jpg
isporeurope.jpeg
1730726358978.jpg

Research Heading

Integrity Life L.L.C, Orlando, Florida, USA

University of Florida, Gainesville, FL, USA

WifOR institute, Darmstadt, Hesse, Germany

Empowered Business Leaders

#careersatintegrity

#jointheteam

Connect Us
logo.png
  • LinkedIn
  • X

Our insights direct to your inbox

bottom of page